Interventional Cardiology & Surgery

heartwire News

Perspective

  • AHA 2018 Think You're Immune From Bias? Think Again John Mandrola, MD, is intrigued by two studies at AHA that track the cognitive and financial biases that may influence what physicians do in practice and how they write and read research papers.
  • CV Risk: Can Prescription Omega-3 REDUCE-IT?   Low-dose omega-3 flopped for CV risk reduction. Melissa Walton-Shirley, MD, dissects the REDUCE-IT trial from AHA, which used high-dose prescription EPA, with principal investigator, Deepak Bhatt, MD.
  • Mandrola Previews AHA 2018 Among the highlights for the upcoming American Heart Association Scientific Sessions are studies on omega-3, inflammation, a potential EP breakthrough, and yoga. Not to mention new lipid guidelines.
  • Vulnerable Plaque: Are Targeted Therapies Within Reach? Recent studies aim to move vulnerable plaque identification into the cath lab routine. Can these tests pinpoint who will benefit most from aggressive pharmacologic therapies and maybe even stents?
www.medicaments-24.com

pharmacy24.com.ua/viagra-sildenafil/viagra-100-mg/viagra-professional-cenforce-professional

www.pharmacy24.com.ua/viagra-sildenafil/viagra-100-mg/viagra-super-active-100-mg-fildena-super-active